Related Experiment Video
Updated: Jan 28, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Prenatal diagnosis and management of congenital complete heart block
Jay D Pruetz1,2, Jennifer C Miller1,2, Gerald E Loeb3
1Department of Pediatrics/Division of Pediatric Cardiology, Children's Hospital Los Angeles, Los Angeles, California.
Insights
Congenital complete heart block (CCHB) in fetuses is serious, with limited prenatal treatments. New minimally invasive pacemakers offer hope for in-utero management, improving outcomes before birth.
Area of Science:
- Cardiology
- Maternal-Fetal Medicine
- Pediatric Cardiology
Background:
- Congenital complete heart block (CCHB) presents significant risks to unborn fetuses, lacking effective prenatal interventions.
- Current treatments, including maternal medications and anti-inflammatory therapies, offer only marginal benefits and cannot reverse CCHB.
- Advances in prenatal diagnosis and surveillance have led to minor improvements in fetal morbidity and mortality.
Purpose of the Study:
- To review current and emerging prenatal interventions for congenital complete heart block.
- To explore the potential of novel technologies like fetal pacemakers for in-utero management of CCHB.
- To identify challenges and future directions in managing CCHB during pregnancy.
Main Methods:
- Review of existing literature on CCHB prenatal management strategies.
- Analysis of current diagnostic and surveillance protocols for fetal heart block.
- Evaluation of preliminary data on emerging therapies, including hydroxychloroquine and intrauterine fetal pacing.
- Discussion of the potential of a fully implantable micropacemaker for fetal intervention.
Main Results:
- Maternal drug administration and anti-inflammatory therapies show limited efficacy in reversing CCHB but may reduce myocarditis.
- Improved prenatal diagnosis and surveillance protocols have slightly reduced CCHB-related morbidity and mortality.
- Intrauterine fetal pacing attempts have been hindered by invasive techniques and lead complications.
- Preliminary research suggests hydroxychloroquine may have a preventive role, though efficacy and safety require further study.
Conclusions:
- Effective prenatal interventions for CCHB remain a critical unmet need.
- Minimally invasive fetal pacemakers represent a promising future strategy for in-utero CCHB management.
- Further research is essential to develop and validate prenatal interventions to manage CCHB until successful postnatal pacemaker implantation.
Abstract:
Congenital complete heart block (CCHB) is a life-threatening medical condition in the unborn fetus with insufficiently validated prenatal interventions. Maternal administration of medications aimed at decreasing the immune response in the fetus and beta-agonists intended to increase fetal cardiac output have shown only marginal benefits. Anti-inflammatory therapies cannot reverse CCHB, but may decrease myocarditis and improve heart function. Advances in prenatal diagnosis and use of strict surveillance protocols for delivery timing have demonstrated small improvements in morbidity and mortality. Ambulatory surveillance programs and wearable fetal heart rate monitors may afford early identification of evolving fetal heart block allowing for emergent treatment. There is also preliminary data suggesting a roll for prevention of CCHB with hydroxychloroquine, but the efficacy and safety is still being studied. To date, intrauterine fetal pacing has not been successful due to the high-risk invasive placement techniques and potential problems with lead dislodgement. The development of a fully implantable micropacemaker via a minimally invasive approach has the potential to pace fetal patients with CCHB and thus delay delivery and allow fetal hydrops to resolve. The challenge remains to establish accepted prenatal interventions capable of successfully managing CCHB in utero until postnatal pacemaker placement is successfully achieved.
Related Concept Videos
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Heart Failure V: Medical Management
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Block Diagram Reduction
The first step in this process is the identification and relocation of a branch point. A branch point, where a...

